Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bachrach

Showing results (661-670 of 677) with videos related to

Pageof 68
Sort By:
Clinical Psychology & Psychotherapy|September 10, 2023
Group schema therapy for cluster-C personality disorders: A multicentre open pilot studyCarlijn J M Wibbelink, Anne-Sophie S M Venhuizen, Raoul P P P Grasman, et al.
Trials|November 28, 2021
The effect of twice-weekly versus once-weekly sessions of either imagery rescripting or eye movement desensitization and reprocessing for adults with PTSD from childhood trauma (IREM-Freq): a study protocol for an international randomized clinical trialCarlijn J M Wibbelink, Christopher W Lee, Nathan Bachrach, et al.
BMC Psychiatry|October 8, 2022
Design of an RCT on cost-effectiveness of group schema therapy versus individual schema therapy for patients with Cluster-C personality disorder: the QUEST-CLC study protocolIuno Z Groot, Anne-Sophie S M Venhuizen, Nathan Bachrach, et al.
Lung Cancer (Amsterdam, Netherlands)|September 10, 2021
Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLCNanruoyi Zhou, Maria A Velez, Benjamin Bachrach, et al.
Nature Communications|March 20, 2024
TacticAI: an AI assistant for football tacticsZhe Wang, Petar Veličković, Daniel Hennes, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|January 27, 2004
Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and childrenAliya A Khan, Laura Bachrach, Jacques P Brown, et al.
Journal of Substance Use and Addiction Treatment|February 2, 2026
Tailoring of a chronic pain self-management intervention for individuals with opioid use disorder in office-based addiction treatmentMegan E Hamm, Ramona Emerson, Shari S Rogal, et al.
The Journal of Clinical Psychiatry|December 19, 2013
A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokersTheresa M Winhusen, Gregory S Brigham, Frankie Kropp, et al.
Nature Cancer|February 5, 2022
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44Amy L Cummings, Jaklin Gukasyan, Henry Y Lu, et al.
Lancet (London, England)|November 19, 2017
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialJoshua D Lee, Edward V Nunes, Patricia Novo, et al.
Pageof 68

Showing results (661-670 of 677) with videos related to

Sort By:
Pageof 68
Clinical Psychology & Psychotherapy|September 10, 2023
Group schema therapy for cluster-C personality disorders: A multicentre open pilot studyCarlijn J M Wibbelink, Anne-Sophie S M Venhuizen, Raoul P P P Grasman, et al.
Trials|November 28, 2021
The effect of twice-weekly versus once-weekly sessions of either imagery rescripting or eye movement desensitization and reprocessing for adults with PTSD from childhood trauma (IREM-Freq): a study protocol for an international randomized clinical trialCarlijn J M Wibbelink, Christopher W Lee, Nathan Bachrach, et al.
BMC Psychiatry|October 8, 2022
Design of an RCT on cost-effectiveness of group schema therapy versus individual schema therapy for patients with Cluster-C personality disorder: the QUEST-CLC study protocolIuno Z Groot, Anne-Sophie S M Venhuizen, Nathan Bachrach, et al.
Lung Cancer (Amsterdam, Netherlands)|September 10, 2021
Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLCNanruoyi Zhou, Maria A Velez, Benjamin Bachrach, et al.
Nature Communications|March 20, 2024
TacticAI: an AI assistant for football tacticsZhe Wang, Petar Veličković, Daniel Hennes, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|January 27, 2004
Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and childrenAliya A Khan, Laura Bachrach, Jacques P Brown, et al.
Journal of Substance Use and Addiction Treatment|February 2, 2026
Tailoring of a chronic pain self-management intervention for individuals with opioid use disorder in office-based addiction treatmentMegan E Hamm, Ramona Emerson, Shari S Rogal, et al.
The Journal of Clinical Psychiatry|December 19, 2013
A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokersTheresa M Winhusen, Gregory S Brigham, Frankie Kropp, et al.
Nature Cancer|February 5, 2022
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44Amy L Cummings, Jaklin Gukasyan, Henry Y Lu, et al.
Lancet (London, England)|November 19, 2017
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialJoshua D Lee, Edward V Nunes, Patricia Novo, et al.
Pageof 68